SMTL ID : 4fod.1

Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 36

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x 0UV: 4-fluoro-N-{(2E)-6-{[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl}-1-[cis-4-(propan-2-ylcarbamoyl)cyclohexyl]-1,3-dihydro-2H-benzimidazol-2-ylidene}benzamide(Non-covalent)

0UV.1: 23 residues within 4Å: Chain A: L.45, G.46, H.47, G.48, V.53, A.71, K.73, V.103, L.119, E.120, L.121, M.122, A.123, G.124, G.125, D.126, E.133, R.176, N.177, L.179, P.183, G.192, D.193 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:A.71, A:L.119, A:L.179, A:P.183 Hydrogen bonds: A:M.122, A:M.122, A:E.133, A:E.133 Water bridges: A:A.49, A:R.176

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 6 residues within 4Å: Chain A: W.243, S.247, Y.250, P.254, P.274, K.275 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.275 Water bridges: A:S.247, A:K.275

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lewis, R.T. et al., The Discovery and Optimization of a Novel Class of Potent, Selective, and Orally Bioavailable Anaplastic Lymphoma Kinase (ALK) Inhibitors with Potential Utility for the Treatment of Cancer. J.Med.Chem. (2012)

Release Date

2012-07-11

Peptides

ALK tyrosine kinase receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK tyrosine kinase receptor

Related Entries With Identical Sequence